Integer Holdings Corporation (ITGR)
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
$126.50+0.80%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · ITGR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 1,843.4 | 1,853.6 | 1,716.6 | 1,555.7 | 1,331.3 | 1,221.1 | 1,073.4 | 1,258.1 | 1,215.0 | 1,461.9 | 1,386.8 | 800.4 | 687.8 | 663.9 | 646.2 | 568.8 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 1,461.9 | 1,386.8 | 800.4 | 687.8 | 663.9 | 646.2 | 568.8 |
| Cost of Revenues | 1,370.0 | 1,353.3 | 1,257.6 | 1,145.8 | 985.5 | 884.1 | 787.7 | 903.1 | 852.3 | 782.1 | 737.8 | 565.3 | 456.4 | 444.6 | 444.5 | 388.5 |
| Gross Profit | 473.5 | 500.4 | 459.0 | 409.9 | 345.8 | 337.0 | 285.7 | 355.0 | 362.7 | 354.0 | 337.7 | 235.1 | 231.4 | 219.3 | 201.6 | 180.4 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 224.1 | 211.7 | 185.2 | 173.2 | 158.1 | 141.4 | 109.0 | 138.7 | 142.4 | 143.1 | 136.4 | 102.5 | 90.6 | 88.1 | 81.0 | 72.5 |
| Other Operating Expenses, Total | — | — | — | — | — | (7.9) | (7.6) | — | — | — | — | — | — | — | — | — |
| Operating Income | 178.8 | 221.3 | 208.2 | 163.3 | 112.7 | 135.7 | 120.6 | 157.6 | 155.6 | 125.6 | 92.9 | 13.1 | 75.7 | 61.3 | 25.8 | 61.7 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 43.2 | 56.4 | 53.4 | 38.6 | 31.6 | 38.2 | 52.5 | 99.3 | 64.0 | 68.3 | 33.5 | 4.3 | 11.3 | 18.1 | 16.9 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | 11.3 | 18.1 | 16.9 |
| Asset Writedown | — | — | — | — | — | — | — | — | — | 0.3 | 0.2 | — | — | — | — | — |
| EBT, Incl. Unusual Items | 136.4 | 125.4 | 147.6 | 105.4 | 68.7 | 101.1 | 86.2 | 105.2 | 61.1 | 49.3 | 28.2 | (15.7) | 76.6 | 48.8 | 6.7 | 48.4 |
| Income Tax Expense | 8.0 | 22.6 | 26.5 | 16.2 | 8.9 | 8.0 | 8.9 | 14.0 | 14.1 | (37.8) | 3.3 | (8.1) | 21.1 | 12.6 | 11.5 | 15.3 |
| Earnings from Continuing Operations | 128.4 | 102.8 | 121.1 | 89.1 | 59.7 | 93.0 | 77.3 | 91.2 | 47.0 | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | 128.4 | 102.8 | 119.9 | 90.7 | 66.4 | 96.8 | 77.3 | 96.3 | 168.0 | 66.7 | 6.0 | (7.6) | 55.5 | 36.3 | (4.8) | 33.1 |
| Per Share | ||||||||||||||||
| Basic EPS | 3.78 | 2.96 | 3.57 | 2.72 | 2.00 | 2.93 | 2.35 | 2.95 | 5.23 | 2.12 | 0.19 | (0.29) | 2.23 | 1.51 | (0.20) | 1.42 |
| Diluted EPS | 3.76 | 2.89 | 3.36 | 2.69 | 1.99 | 2.91 | 2.33 | 2.92 | 5.15 | 2.08 | 0.19 | (0.29) | 2.14 | 1.43 | (0.20) | 1.40 |
| Revenue per Share | 53.99 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 34.0 | 34.7 | 33.6 | 33.3 | 33.1 | 33.0 | 32.8 | 32.6 | 32.1 | 31.4 | 30.8 | 26.4 | 24.8 | 24.0 | 23.6 | 23.3 |
| Diluted Weighted Avg Shares | 34.1 | 35.6 | 35.6 | 33.8 | 33.4 | 33.3 | 33.1 | 33.0 | 32.6 | 32.1 | 31.0 | 26.4 | 26.0 | 25.3 | 23.6 | 23.6 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 351.9 | 319.3 | 262.2 | 204.7 | 217.1 | 199.9 | 235.5 | 244.5 | 228.4 | 183.4 | 57.8 | 112.9 | 97.3 | 72.2 | 98.0 |
| EBIT | 178.8 | 221.3 | 208.2 | 163.3 | 112.7 | 135.7 | 120.6 | 157.6 | 155.6 | 125.6 | 92.9 | 13.1 | 75.7 | 61.3 | 25.8 | 61.7 |
| Effective Tax Rate | 5.9% | — | — | 15.4% | 13.0% | 8.0% | 10.4% | 13.3% | 23.0% | -76.8% | 11.7% | 51.6% | 27.6% | 25.7% | 171.3% | 31.6% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.